Yevhenii Kondratiuk / Shutterstock.com
Against a backdrop of record growth in sustainable food production, two US makers of plant-based foods lock horns in a patent dispute with potentially wider consequences, reports Sarah Speight.
How should the tension between collaboration and competition be balanced when benefits to people and planet are on the table? That is one question raised by a patent dispute between two big US-based players in the manufacture of plant-based foods.
Heme proteins (or hemoproteins) are key ingredients in both manufacturers’ meat-alternative products. Impossible markets a plant-based meat (PBM), while Motif markets a cell-based meat product (CBM)—a distinction argued in the lawsuit.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at firstname.lastname@example.org
Impossible Foods, Motif FoodWorks, patents, US, Europe, USPTO, EPO, plant-based foods, technology, sustainability, green tech, agri-tech, inventions